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Abstract: Macrophages play a key role in the foreign body response. In 
this study it was investigated whether obesity affects the acute response 
of macrophages to biomaterials in vitro and whether this response is 
associated with biomarkers in blood. CD14+ monocytes were isolated from 
blood from obese and age and gender matched lean persons.  Monocyte 
subsets were determined based on CD14 and CD16 on their surface. C-
reactive protein (CRP) was measured in peripheral blood. The response of 
monocyte-derived macrophages to polypropylene (PP), polylactic acid 
(PLA), polyethylene terephthalate (PET) monofilament, and PET-
multifilament (mPET) in culture was based on cytokine production. More 
IL-6 (for PET), less CCL18 (all materials) and IL-1ra (for PLA) was 
produced by macrophages from obese patients than lean subjects. Body mass 
index, serum CRP and to a lesser extend percentages of monocyte subtypes 
correlated with IL-6, TNFα, CCL18, and IL-1ra production. Taken together, 
monocyte-derived macrophages of obese patients respond more pro-
inflammatory and less anti-inflammatory to biomaterials than macrophages 
from lean subjects, depending on the material. These results are a step 
towards personalized medicine for the development of a model or even a 
blood test to decide which biomaterial might be suitable for each 
patient. 
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 Reviewer #1:  
Leptin, which is secreted by adipocytes, would be of interest as a parameter for obesity in 
addition to CRP. Please provide a rational for the selection of the clinical parameters in 
the introduction. 
answer: We thank the reviewer for his/her suggestion to measure leptin. Our aim 
was to examine the effect of obesity on the macrophage-biomaterial interaction and 
whether this correlates to parameters in the blood in a clinical context. CRP was 
therefore chosen because it is indeed a standard clinical parameter for general 
inflammation and it was used as a standard measurement prior to surgery in our 
patient population, especially in people undergoing bariatric surgery. This is now 
also added to the introduction/materials and methods. 
 
Experimental setup should be better described. The manuscript would benefit from a 
picture of the culture system, samples, and experimental approach. 
answer: We apologize for being not clear in the experimental set up. A diagram is 
made to provide more clarity.  
 
For the biomaterial study, yarn was used. From our experience achieving consistent 
seeding results on yarn or structured materials is difficult. How do the authors ensure that 
cells stayed on the biomaterial during culture and did not attached to the culture vessel? 
Please elaborate the description of the culture device and the seeding method. 
answer: Before conducting the study with patient cells, pilot experiments were 
performed to determine the optimal material configuration allowing as much cells 
to be attached as possible. Disks, meshes and braided yarns (spool knit) were 
compared and the braided yarns resulted in the highest DNA amount directly after 
seeding and after culture. The braided materials are created of a mix of micro- and 
macro-porosity that favors cell attachment, particularly for monofilaments, and 
even more particularly, for polypropylene monofilaments. We did not make any 
effort to ensure cells would stay on the biomaterials. However, to ensure that 
medium is only conditioned by cells that adhered to the material and not by cells 
that adhered to the culture well, the yarns were replaced into new culture wells 24 
hours prior to harvesting the culture medium. The culture system and seeding 
method is now included in the drawing that also depicts the experimental setup. 
 
Furthermore, the cell surface ratio should be standardized for all materials. Otherwise 
interpretation of results is not possible. The currently used normalization on density does 
not consider the surface for cell attachment. 
answer: All tested materials were braided according to a similar pattern and with 
same volumic density, corrected by the g/cm
3
 values by each material. Since cell 
attachment was indeed different between materials, also because of different 
properties of the materials, we normalized the protein data to the amount of DNA as 
an indication for the cell number. We think that by normalizing for DNA, we adjust 
for variation in cell number allowing us to have a clear image of the production of 
cytokines per cell, not influenced by the number of cells that adhered to the 
material. More information on this is now provided in the materials and methods. 
 Cytokine panel for characterization of pro- or anti-inflammatory effects is rather low. In 
general, higher numbers of different cytokines are used to characterize the material-cell 
interaction, e.g. Jaguin, M., et al. (2013) Cell Immunol 281(1): 51-61, Verreck, F. A. W., 
et al. (2006) Journal of Leukocyte Biology 79(2): 285-293. 
answer: Indeed, very often, many cytokines are measured to examine the response 
of macrophages to biomaterials. However, we had a limited amount of culture 
medium due to the low number of macrophages available from the patients and 
healthy volunteers. In addition, in our previous studies, we saw that IL6, TNFalpha, 
IL1ra and CCL18 are the most discriminative for different phenotypes of 
macrophages (1, 2). Even though it is a rather small panel of cytokines, we think 
that this panel allows us to determine the phenotype and behavior of the 
macrophages in response to the material. The rationale behind our choice of 
cytokines is now more clearly explained in the Materials and Methods. 
 
In the introduction, the authors describe that TNF-alpha and IL-6 is increased in obese 
people. This indicates, that data should be normalized to the base level of secretion 
without biomaterial contact. Thus, interpretation of the results is difficult. 
answer: We thank the review for this remark. Indeed, obese people have increased 
circulating levels of TNFalpha and IL6, most likely produced by many types of cells 
than the macrophages alone. This is now clearer stated in the introduction. We do 
not agree however that data should be normalized to baseline levels because this is 
also not what happens in a clinical situation. Most likely, the fact that baseline (i.e. 
prior to implantation of a material) production is increased in some patients, 
contributes to the differences seen after implantation. In addition, even though 
corrections were not made for baseline levels, still differences are seen between the 
effect of biomaterials on cells of the same patient. This is now discussed in the 
discussion section.  
 
The used cells for material incubation are not described and characterized regarding their 
macrophage identity. Although the monocytes are identified via CD-14 and CD-16, the 
differentiated macrophages are neither characterized nor differentiation is externally 
induced by growth factors. Characterization of biomaterial-adherent cells through 
immune histological staining should be conduct to confirm the macrophage M1/M2 
index. 
answer: We have extensive experience with macrophage culture, and after 
monocyte isolation and adherence to the culture substrate in the presence of 20% 
FCS, they differentiate into macrophages expressing the typical macrophage genes 
(1-4). We believe that by determining the cytokine production of TNFalpha, IL6, 
CCL18, and IL1ra we can determine the behavior and phenotype of the cells (1), 
rather than by determining the presence of cell surface markers that do not provide 
information on the behavior of the cells. 
 
Following cell incubation, biomaterials are transferred to a 96-well plate. Thereby, non-
adherent cells are excluded from the following investigations. Nevertheless, in vivo, the 
ecm as well as the cells in the proximity of the biomaterial contribute to the foreign body 
response. Please provide a rational for considering only the biomaterial-adherent cell 
fraction. 
answer: We thank the reviewer for this interesting and valid point. The rationale 
behind transferring the materials with adherent cells to new wells, was to measure 
indeed only the cytokines that were produced by the adherent cells allowing us to 
determine the protein production in response the biomaterials of interest only not 
being overshadowed by the effect TCPS might have on the macrophages, which is in 
fact also a biomaterial that has an influence on macrophages. TCPS most likely will 
have a totally different effect than the extracellular matrix that normally surrounds 
an implanted biomaterial. In fact, we have seen that collagen indeed exerts different 
effect on macrophages than polymers (2, 3). We included the remark of this 
reviewer about the effect of the ECM and macrophages in the close proximity in the 
discussion and added our rationale behind only measuring the cytokine production 
of the adherent cells. 
 
In our studies, we observed differences between thawed and fresh macrophages regarding 
the cluster of differentiation. Please add supplementary data that shows that CD-14 and 
CD-16 are unaffected by freezing and thawing. 
answer: Indeed, cell death was observed after freezing and thawing. However, the 
percentages of monocyte subsets remained the same after thawing the cells again. 
We agree with the reviewer that more information on flow cytometric analysis 
should be given and we have now added plots of analyzed fresh cells and cells from 
the same donor that were frozen, also providing information on how measurements 
were done. 
 
Usually, for an ELISA measurement 100 µl of sample is required. In the culture device, 
the author's state that 125 µl per test conditions is available. Conditions were provided in 
triplicates, which results in a total volume of 375 µl per condition. Please explain how 4 
different cytokines - requiring approximately 100 µl - could be measured based on the 
limited sample volume. Are diluted concentration within the detection limit of the 
assays? 
answer: We apologize for being unclear about this. Indeed, 125 µl of culture 
medium was used per well, performed in triplicate. These triplicates were kept 
separately, allowing us to measure every condition and experiment in triplicate. 
Since from experience and pilot experiments we knew that certain materials 
induced certain levels of cytokines, we knew that medium needed to be diluted 
several times prior to measurement. Since every material resulted in different 
dilutions for the different cytokines, we did not include the dilution factors, because 
this would lead to 16 different dilutions (4 materials and 4 cytokines). However, to 
give the reviewer an idea, the dilutions ranged from 3x to 100x, depending on the 
material and the cytokine. In addition, all measurements fitted within the standard 
curve, and if the value was too low, measurements were repeated with a lower 
concentration. More information is now provided in the methods section about the 
measurements of the cytokines. 
 
Cytokine concentrations in FCS may impact the experiment. Relevant controls (I) passive 
adsorption of measured proteins on material surface, and (II) concentration of IL-6. IL-
1ra, and TNF-alpha in FCS are missing. Measured cytokines usually can be found in the 
supplemented serum, and by binding to the surface, differences of cytokine 
concentrations could be explained by this effect. Measured cytokine concentrations 
should be interpreted in relation to blank medium following biomaterial incubation. 
answer: We thank the reviewer for this remark and we agree that proper controls 
should be added. We now included a figure in which we determined the adsorption 
of our cytokines of interest to the materials and showing the values of these 
cytokines in our blank culture medium. As can be seen, our proteins of interest were 
not detectable in blank culture medium, and thus no adsorption was seen in blank 
culture medium. After spiking of these cytokines and chemokines however, 
adsorption was seen, and varying between the materials. Mostly, associations are 
made within a biomaterial. These comparisons and associations are therefore 
unaffected in our opinion. In figure 2, we are comparing materials with each other. 
Since PP had the most adsorption of our proteins of interest, the values for PP (and 
for PLA in the case of IL6) are most likely an underestimation. This is now added to 
the discussion. 
 
Furthermore, the authors state that "the topography was not exactly the same", and thus 
the surface area was not comparable. Thus, differences of protein adsorption on different 
materials are increased and interpretation of results is difficult. Thus, measurements 
should be normalized to surface area. 
answer: We now measured protein adsorption on the different materials and 
indeed, differences are seen in adsorption between materials. As mentioned in the 
answer above, most of the associations and comparisons are made within a 
biomaterial and a cytokine, not comparing two different cytokines or materials with 
each other, but comparing obese and lean patients, head and head, for all material - 
cytokine combinations. These comparisons and associations are therefore unaffected 
in our opinion by the adsorption of the protein of interest. This is now added to the 
discussion. Specific area is hard to be evaluated due to i) stitches shadowing some 
possible areas, ii) stitches creating micro porosity which favors cell adhesion, iii) 
multifilament with theoretical much higher surface area, but real surface much 
reduced due to compaction of the filaments of the multifilament yarns. To minimize 
differences in surface area, the amount of materials incubated with cells were 
adjusted in such a way to get the same volume of material for each tested material 
PET, mPET, PP, and PLA. 
 
Standard deviations of absolute protein production per individual for both groups (lean 
and obese people) are high and indicate that the readout depends on an unknown 
parameter that seems to exhibit an impact comparable to obesity. Please discuss. 
answer: We agree with the reviewer that it is clear that not only obesity probably 
influenced the response of the macrophages to the biomaterials. We made an effort 
to rule out as many as possible other factors such as smoking, recent implantation of 
a biomaterial, diabetes mellitus or the use of immunosuppressive drugs but other 
unknown factors can still be of influence. This is now added to the discussion. 
 Calculation of the M1/M2 index is rather unclear, even inconsistent. When comparing the 
methods and the results part, different definitions are given. 
answer: We apologize for the apparent inconsistency. Accidentally the M2/M1 index 
was written in the materials and methods but this must be M1/M2 index as 
described in the results. We adjusted the description of the calculation hoping to be 
more clear in this.  
 
There seems to be quite a lot of mathematics, and regarding the high standard deviations 
of the measured concentrations (Figure 2F) that are used to calculate the M1/M2 index, 
the small deviations depicted for the M1/M2 index is difficult to understand. 
answer: For every cytokine, normalization was performed to the average of that 
cytokine level in the response to the biomaterial. Therefore, standard deviations are 
small. We hope that by explaining the calculation of the M1/M2 index in more 
detail, this is made clearer. 
 
In contrast to CCL18, IL-6 is secreted in a 100-fold higher range, and thus weighting in 
the M1/M2 index is biased by cytokines exhibiting higher concentration ranges. Thus, 
concentrations should be normalized and scaled. 
answer: Indeed, for the calculation of the M1/M2 index, a normalization is 
performed for every cytokine to its average within the measurements for that 
biomaterial. This prevents that a cytokine that is produced at higher levels has more 
influence on the index than a cytokine that is produced at lower levels. We hope that 
our earlier adjustments made this more clear. 
 
I appreciate the personalized-medicine-aligned study approach that considers health 
factors of individual patients. Furthermore, to aim at a blood test that facilitates the 
identification of biomaterials suitable for a specific patient is of great interest. However, 
study design requires further controls to allow a sound characterization of the 
biomaterial-patient interaction. Furthermore, test conditions are not standardized (cell 
identity, surface area). My recommendation is to reject the manuscript. 
answer: We thank the reviewer for his appreciation for our personalized-medicine-
aligned study approach and we hope that by addressing his comments in detail, 
made adjustments, and added controls, this reviewer now thinks our paper is ready 
for publication. 
 
 
Reviewer #2: 
This is a rather phenomenological, and it is unclear if the in vitro results really represent 
what happens in vivo. However, the presented results open an interesting scenario worth 
to investigate and discuss among the scientific community, with potential impact on 
personalized treatments after surgery and in regenerative medicine. Therefore, this article 
merits consideration by biomaterials audience with some revisions to improve the quality 
of the manuscript 
answer: We thank the reviewer for pointing out the relevance of our paper. We 
agree that results should not be over interpreted but that our study opens up 
interesting perspective for future research and application. Therefore we adjusted a 
few of our sentences in the conclusions section. 
 
1. In the abstract authors claim: " These results are a step towards personalized medicine 
for the development of a model or even a blood test to decide which biomaterial might be 
suitable for each patient." I disagree with the authors. There is no clear material-specific 
differences among the materials tested. There is a difference between obese and lean, and 
in most data the trends are similar among the tested materials. 
answer: In supplementary former figure 2F, comparisons are made between the 
cytokine levels in response to the different materials. From this graph, we concluded 
that there are indeed different responses in the macrophages in response to the 
different biomaterials. In addition, as this reviewer points out later, differences are 
seen on the M1/M2 index that is based on all these cytokines. We now made this 
figure one of the main figures, since a part of our conclusion is based on these 
results. 
 
2. In each figure (in the manuscript and in the supporting information) the number of 
different samples ("n") used for the experiments should be specified. This has only been 
done for some figures and is relevant to assess the significance of the results (authors say 
that they discharged certain subpopulations for the different tests) 
answer: We thank the reviewer for pointing this out and added this information to 
all the figures.  
 
3. The gender distribution among the samples was male/female 2/18. This should be 
specified not only on Table 1 but also in the experimental part. 
answer: We agree with the reviewer and added this information to the plots in 
which individual measurements are shown (supplementary figure 2A-D). Since the 
distribution of male/female is different for every material and measured cytokine, 
we choose not to add it to the other figures, because this would decrease the clarity 
of the figures.  
 
4. Figure 1: M1/M2 index between lean and obese patients changes is much larger on 
mPET than on PET, although it is the same material. Author should comment on this. 
answer: This is indeed an interesting point raised by the reviewer and it shows that 
not only the polymer itself is important for the response of the macrophages to the 
material, but also the architecture of the material. This is now clearer discussed in 
the discussion section.  
 
1. Utomo L, van Osch GJ, Bayon Y, Verhaar JA, Bastiaansen-Jenniskens YM. 
Guiding synovial inflammation by macrophage phenotype modulation: an in vitro 
study towards a therapy for osteoarthritis. Osteoarthritis Cartilage. 2016 Apr 14. 
2. Grotenhuis N, Bayon Y, Lange JF, Van Osch GJ, Bastiaansen-Jenniskens YM. A 
culture model to analyze the acute biomaterial-dependent reaction of human 
primary macrophages. Biochem Biophys Res Commun. 2013 Mar 29;433(1):115-20. 
3. Grotenhuis N, Vd Toom HF, Kops N, Bayon Y, Deerenberg EB, Mulder IM, van 
Osch GJ, Lange JF, Bastiaansen-Jenniskens YM. In vitro model to study the 
biomaterial-dependent reaction of macrophages in an inflammatory environment. 
Br J Surg. 2014 Jul;101(8):983-92. 
4. Fahy N, de Vries-van Melle ML, Lehmann J, Wei W, Grotenhuis N, Farrell E, 
van der Kraan PM, Murphy JM, Bastiaansen-Jenniskens YM, van Osch GJ. Human 
osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem 
cells via macrophage polarisation state. Osteoarthritis Cartilage. 2014 
Aug;22(8):1167-75. 
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Monocyte subsets in blood correlate with obesity related response of 
macrophages to biomaterials in vitro.  
G.S.A. Boersemaa,b, L. Utomob, Y. Bayonc, N. Kopsb, E. van der Harstd, J.F. Langea, Y.M. Bastiaansen-
Jenniskensb 
 
 aDepartment of Surgery, Erasmus MC, University Medical Center Rotterdam, The Netherlands 
 bDepartment of Orthopaedics, Erasmus MC, University Medical Center Rotterdam, The Netherlands 
cMedtronic-Sofradim production, 116 Avenue Formans, 01600 Trévoux, France 
dDepartment of Surgery, Maasstad Hospital, Rotterdam, the Netherlands 
 
 
 
 
 
 
 
 
 
 
Corresponding author 
Y.M. Bastiaansen-Jenniskens, PhD 
y.bastiaansen@erasmusmc.nl 
Department of Orthopedics  
Wytemaweg 80, Ee1651b, 3015 GE Rotterdam 
Erasmus MC, University Medical Center 
Tel: +31-10-7044626 
Fax: +31-10-7044690 
  
Manuscript
Click here to download Manuscript: Biomaterials Manuscript Informed trial 27062016 blank.docxClick here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Abstract 
 
Macrophages play a key role in the foreign body response. In this study it was investigated whether 
obesity affects the acute response of macrophages to biomaterials in vitro and whether this response 
is associated with biomarkers in blood. CD14+ monocytes were isolated from blood from obese and 
age and gender matched lean persons.  Monocyte subsets were determined based on CD14 and 
CD16 on their surface. C-reactive protein (CRP) was measured in peripheral blood. The response of 
monocyte-derived macrophages to polypropylene (PP), polylactic acid (PLA), polyethylene 
terephthalate (PET) monofilament, and PET-multifilament (mPET) in culture was based on cytokine 
production. More IL-6 (for PET), less CCL18 (all materials) and IL-1ra (for PLA) was produced by 
macrophages from obese patients than lean subjects. Body mass index, serum CRP and to a lesser 
extend percentages of monocyte subtypes correlated with IL-6, TNFα, CCL18, and IL-1ra production. 
Taken together, monocyte-derived macrophages of obese patients respond more pro-inflammatory 
and less anti-inflammatory to biomaterials than macrophages from lean subjects, depending on the 
material. These results are a step towards personalized medicine for the development of a model or 
even a blood test to decide which biomaterial might be suitable for each patient. 
 
Keywords: biomaterials, in vitro model, obesity, monocyte subsets, macrophages 
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Introduction 
Biomaterials are often used in several surgical disciplines such as urology, gynaecology and general 
surgery[1]. The foreign body response to implanted biomaterials is crucial for adapting the material 
in the human body. Macrophages play a key role in the foreign body reaction to biomaterials[2]. For 
regenerative biomaterials, an initial pro-inflammatory (M1) response is necessary for recruiting 
inflammatory cells to encourage the foreign body response, which are necessary events for wound 
healing including ingrowth. However, a prolonged M1 response results in fibrous capsule formation 
and extended inflammation. Therefore, a subsequent transition to the anti-inflammatory 
macrophages (M2), which promotes tissue repair and remodeling, is generally presumed to be the 
preferred modification[3]. Achieving the desired outcome is individual and biomaterial dependent. 
In general, obesity seems to be an important factor for adverse outcomes after surgery. Observed 
complications are surgical site infections, impairment of cutaneous wound healing, wound failure, 
anastomotic leakage, and fascia dehiscence[4-6]. These complications are major risk factors to 
develop incisional hernia or a recurrent incisional hernia after repair[7, 8]. Potential factors that 
increase wound complications by obesity include intrinsic tenuous anatomic properties, poor 
vascularization, and cellular and molecular alterations. Inflammatory mediators such as tumor 
necrosis factor alpha (TNFα), interleukin 6 (IL-6), leptin, and angiotensin increase simultaneously with 
increasing mass of adipose tissue and adipocyte size[4]. These factors negatively affect wound 
healing and are most likely produced by many types of cells than macrophages alone. Obesity is also 
positively correlated with oxidative stress which can lead to decreased oxygen tension and impaired 
fibroblast proliferation and collagen synthesis[4]. 
Due to obesity, macrophages undergo a phenotypic switch from M2 to M1, which leads to a chronic 
low-grade systemic inflammation[9-13]. Monocytes, the precursors of macrophages, can be divided 
into subsets, according to their expression of the cell surface antigens CD16 (Fc receptor III) and 
CD14 (a receptor for bacterial lipopolysaccharide (LPS))[14]. The classical monocyte has high CD14 
(CD14++) cell surface expression and is CD16 negative (CD16-). The non-classical monocyte also 
expresses CD14 at its surface but at an approximately ten times lower level than the classical 
monocyte (CD14+), and is positive for CD16 (CD16++). The intermediate monocyte expresses CD14 at 
a high level (CD14++), and CD16 at an approximately ten times lower level than the non-classical 
monocyte (CD16+). In general, monocytes expressing CD16 have a high phagocytic capacity and 
produce more pro-inflammatory cytokines such as TNFα and IL-6, and are therefore considered pro-
inflammatory [15]. The classical CD14++/CD16- subset is the predominant population and accounts for 
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approximately 90% in healthy persons. It has been suggested that obesity leads to a shift from 
classical towards intermediate and non-classical monocytes[16, 17]. 
Previous in vitro models have shown that culturing macrophages isolated from healthy donors on 
different biomaterials leads to a biomaterial-specific reaction[18] and that even in a contaminated in 
vitro model, surgical biomaterials still elicit differential reactions in macrophages[19]. These in vitro 
models did not take into account patient specific characteristics, such as age, smoking, diabetes or 
obesity. Obesity is a growing healthcare issue in the clinics and a subgroup of these patients does 
receive a biomaterial for several reasons like abdominal wall hernia with an increased risk of 
unwanted reactions to the biomaterial or delayed wound healing[4, 5]. Therefore, the aims of this 
study were to investigate how obesity affects the acute host response of macrophages to 
biomaterials in vitro and to examine whether this in vitro response can be predicted beforehand by 
determining monocyte subsets in the blood or by measuring the systemic inflammation marker CRP 
that is a common used clinical parameter for inflammation.  
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Methods 
Study population 
In total we included 20 obese patients and 20 age and gender matched healthy, lean (BMI 18-25 
kg/m2) volunteers. Obese patients with a BMI >30 kg/m2 were included at the department of bariatric 
surgery at the Maasstad Hospital, Rotterdam. Exclusion criteria for both groups were smoking, 
diabetes mellitus, use of immunosuppressive drugs, autoimmune disease or chronic inflammatory 
disease, and medical history such as previous surgery or having a prosthesis (e.g. vascular implants, 
mesh, osteosynthesis material). This study was approved by the Medical Ethical Committee of the 
Erasmus University Medical Center, Rotterdam, Netherlands, in accordance with the Dutch law on 
medical research in humans. Permit number MEC-2014-221, NL47780.078.14. Written informed 
consent was obtained from all patients. 
Biomaterials 
Four types of biomaterials were selected for use in all experiments: polypropylene (PP; 0.9 g/cm3), 
polyethylene terephthalate multifilament (mPET; 1.34 g/cm3), polyethylene terephthalate 
monofilament (PET; 1.34 g/cm3) and polylactic acid (PLA; 1.25 g/cm3) (Figure 1). All materials were 
provided as yarns braided in the same conformation.  All tested materials were braided according to 
a similar pattern and with same volumic density, corrected by the g/cm3 values by each material. The 
braided materials are created of a mix of micro- and macro-porosity that favors cell attachment, 
particularly for monofilaments, and even more particularly, for polypropylene monofilaments. 
Monocyte isolation and seeding on biomaterials 
Peripheral blood mononuclear cells (PBMC) were isolated from 30 mL blood of obese patients and 
healthy volunteers by gradient density separation using Ficoll-Paque PLUS (GE Healthcare Life 
Sciences, Little Chalfont, UK). The blood from the obese patients was obtained preoperatively to 
bariatric surgery. Monocytes were isolated by CD14+ selection. Briefly, the blood was diluted 1:1 with 
PBS (Gibco; Carlsbad, USA) supplemented with 0.1% BSA (Sigma-Aldrich, St. Louis, USA), applied on 
top of a Ficoll layer, and centrifuged at 900 x g for 30 minutes to acquire separation of layers. The 
interphases were collected and washed twice with PBS/0.1% BSA before a 20 minute incubation at 
4⁰C with anti-human CD14 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Positive 
selection was performed by Magnetic-acitvated cell sorting (MACS). The isolated CD14+ monocytes 
were kept in suspension in X-VIVOTM 15 medium (Lonza, Verviers, Belgium) containing 20% heat 
inactivated fetal calf serum (FCS; Lonza), 50 µg/mL gentamicin (Gibco) and 1.5 µg/mL amphotericin B 
(Fungizone; Gibco), from now on referred to as ‘culture medium’, until seeding. Prior to seeding, the 
biomaterials were pre-conditioned in non-heat inactivated FCS for 2 hours at 37⁰C with agitation. 
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After pre-conditioning, the monocytes were seeded by rotation onto the biomaterials for 2 hours at 
37⁰C at 20 rpm (VWR tube rotator, Radnor, Pennsylvania, USA). The materials were exposed to 
850,000 monocytes per yarn at a concentration of 500,000 monocytes/mL. After seeding, the 
materials were carefully transferred to 96-well plates (Corning Costar, NY, USA) and cultured in 125 
µL culture medium per well. Per patient, four different materials in triplicate were cultured. The 
culture system is shown in Figure 1. After 2 days of culture, the materials were transferred to new 
wells and medium was refreshed to only take into account the biomaterial adherent cells. Twenty-
four hours after refresh, the medium was collected while keeping the three samples separate, 
centrifuged for 10 minutes at 300 x g and stored at -80⁰C for later cytokine quantification. The 
macrophages adhering to the biomaterials were lysed in 125 µL PBS/0.1% Triton-X (Sigma-Aldrich) 
and stored at -20⁰C before DNA quantification. The remaining CD14+ monocytes that were not used 
for seeding were stored in 20% dimethyl sulfoxide (DMSO)/FCS in liquid nitrogen for flow cytometric 
analysis. 
 
Protein adsorption by the biomaterials 
To evaluate potential adsorption of the proteins by the materials, the materials were pre-conditoned 
for 2 hours in non-heat inactivated FCS with agitation, followed by 2 hours incubation in X-VIVO/20% 
FCS in a tube rotator at 37°C. Next, the materials were transferred to well plates and incubated in X-
VIVO/20% FCS for 2 days. After this period, the materials were transferred to new well plates and 
incubated in medium containing either 1 ng/mL IL-6 (Peprotech), 250 pg/mL CCL18 (R&D Systems),  
1.25 ng/mL IL 1RA (R&D Systems),  500 pg/mL TNFα or no cytokine. After an additional incubation 
day, the media were harvested, centrifuged at 300 x g and stored at -80°C until cytokine 
quantification. The use dosages were based on the detection ranges of the enzyme-linked 
immunosorbent assays (ELISAs) that were used to determine cytokine concentrations.   
Cytokine quantification 
Enzyme-linked immunosorbent assays (ELISAs) were performed according to manufacturer’s 
instructions to quantify the concentrations of CCL18, IL-1ra, IL-6, and TNFα (R&D Systems, 
Minneapolis, MN, USA)  released in the cell culture supernatants. These selected cytokines were 
chosen based on our previous research in which CCL18, IL-1ra, IL-6, and TNFα were the most 
discriminative for the different macrophages phenotypes [18, 20]. All measurements fitted within the 
standard curve, for every material and cytokine different dilutions had to be made of the culture 
medium, ranging from a 3 to 100 times dilution. C-Reactive Protein (CRP) levels in the plasma were 
determined using the standard technique at the hospital’s laboratory (Dimension Vista® System, Flex 
reagent cartridge, Siemens Healthcare Diagnostics Products, Germany) and expressed in mg/L. CRP is 
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a very common used parameter in all hospitals to detect early systemic inflammation, also prior to 
surgery, especially in obese patients. 
 
DNA quantification 
Since cell attachment was different between materials we normalized the protein content in the 
culture media to the amount of DNA on the biomaterial as an indication for the cell number. By 
normalizing for DNA, we adjust for variation in cell number allowing to determine the production of 
cytokines per cell, not influenced by the number of cells that adhered to the material. DNA was 
quantified with a modified CYQUANT® cell proliferation assay (Invitrogen, Carlsbad, California, USA), 
in order to normalize the cytokine production for the number of cells. In short, the samples were 
sonicated for 30 minutes at 48 kHz to completely disintegrate the cells. Next, a solution containing 
250 IU heparin (LEO Pharma, Ballerup, Denmark) and 125 µg RNAse (Sigma-Aldrich) were added to 
the suspensions and incubated for 30 minutes at 37°C. Finally, 0.375 µL CyQUANT GR dye was added 
to each sample and fluorescence was immediately measured on a SpectraMax Gemini micro plate 
reader (Molecular Devices, Sunnyvale, USA) at 480 nm excitation and 520 nm emission. 
 
Flow cytometric analysis 
Monocytes were thawed from -80°C and re-suspended at 500,000 cells/mL in FACSFlow solution (BD 
Biosciences) and stained for 30 minutes at 4°C with antibodies against human CD14 conjugated with 
APC-H7 and CD16 conjugated with PE (both BD Biosciences), according to the manufacturer’s 
guidelines. Unstained cells were used as negative control. Flow cytometric analysis was performed 
using the FACSJazz™ (BD Biosciences), and data were analyzed using FlowJo (FlowJo v7.6.4/v10; 
Ashland, OR, USA). As can be seen in supplementary Figure 1, cells changed in shape and granularity 
(A and C), and most likely because of cell death, less cells were stained with either of the two 
antibodies after freezing and thawing. Percentages of monocytes subsets remained however 
comparable (B and D).  
 
Statistical analysis 
Statistical analysis was performed with SPSS 21.0 (IBM Inc., Chicago, USA). Basic characteristics are 
presented as mean ± standard deviation (SD) and data related to cytokines are presented as mean 
and standard of mean (S.E.M.). An independent T-test was used for the age and BMI due to normal 
distribution of these parameters. Mann Whitney U analysis was used for statin use. To compare 
cytokine levels between macrophages obtained from lean and obese subjects and compare cytokine 
levels between the different materials within the obese and control group, a Kruskal-Wallis analysis 
followed by a post-hoc Mann Whitney U analysis was performed. An M1/M2-index per material was 
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calculated based on the cytokine production of pro-inflammatory (M1) cytokines IL-6 and TNFα and 
anti-inflammatory (M2) cytokines CCL18 and IL-1ra. The mean of the relative M1 cytokine levels per 
patient to the overall M1 cytokine levels of all patients, was divided over the mean of the relative M2 
cytokine levels per patient to the overall M2 cytokine production of all patients, as shown in the 
following formula.  
              
                                  
                                                                         
                                    
                                                                             
 
To determine correlations, a non-parametric Spearman test was performed. All reported p-values 
were two-sided; a p-value < 0.05 was considered to indicate statistical significance. Since the 
analyses were exploratory and the groups sizes small, no adjustment for multiple testing was 
performed. 
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Results 
As a result of our inclusion criteria, BMI was significantly different between the included lean and 
obese subjects. Age, gender and the use of statins were not significantly different between the two 
groups (Table 1). 
 
Obesity influenced cytokine production by macrophages on biomaterials 
The production of IL-6 and TNFα as indicators for a pro-inflammatory response and CCL18 
and IL-1ra as indicators for an anti-inflammatory response were measured. Macrophages from obese 
patients produced significantly more IL-6 than macrophages from lean subjects when cultured on PET 
(144.0 pg IL-6/ng DNA vs 102.0 pg IL-6/ng DNA, p = 0.022). No significant differences were seen for 
the other materials regarding IL-6 production (Table 2 and Supplementary Figure 2A). TNFα 
production was not significantly different between the groups for any of the tested materials (Table 2 
and Supplementary Figure 2B). CCL18 production was significantly higher for all materials in the lean 
group than in the obese group (Table 2 and Supplementary Figure 2C). IL-1ra production was higher 
in the lean group than in the obese group when cultured on PLA (34.6 pg IL-1ra/ng DNA vs 15.5 pg IL-
1ra/ng DNA, p = 0.026) but not on the other materials (Table 2 and Supplementary Figure 2D). 
No IL-6, TNFα, CCL18, and IL-1ra were detectable in medium with serum alone and thus also 
no difference was seen after incubation of the material in medium with serum but without adherent 
cells. When the proteins of interest were spiked in the culture medium, adsorption of these proteins 
was seen to the materials, with the most adsorption of all four proteins to PP, and PLA in the case of 
IL-6 (Figure 2).     
The DNA concentration as an indication for the number of attached macrophages to the 
biomaterials, was not significantly different between the lean and obese patients in all biomaterials 
(Supplementary data Figure 3A). Absolute protein production per individual is shown in 
supplementary Figure 2B-D. When comparing the effect of the materials on macrophages within the 
obese and lean group and per material, PP induced higher levels of IL-6, TNFα, and IL-1ra than the 
other materials, especially when compared to mPET. Less clear differences between materials were 
seen for CCL18 production (Figure 3). 
To compare overall response of the different materials in lean and obese subjects, an M1/M2 
index was calculated for each condition. The M1/M2 index was significantly higher of the obese 
group than for the lean subjects for PP (p < 0.001), PET (p = 0.001), and mPET (p = 0.003) but not for 
PLA. No differences regarding the M1/M2 index were seen between materials for the lean subjects. 
In obese patients, PLA resulted in the lowest M1/M2 index, and mPET the highest (Figure 4).  
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Serum CRP and BMI correlate with cytokine production by macrophages 
The average C-reactive protein level in lean subjects was 1.3 ± 1.8 mg/L versus 15.6 ± 17.1 
mg/L in obese patients, p = 0.004 (Supplementary Figure 4). CRP concentration positively correlated 
with BMI (Table 3). A positive correlation was also seen between CRP and IL-6 production in response 
to the material for all materials, but only significant for PP and mPET. A significant negative 
correlation was seen between serum CRP concentration and CCL18 production by macrophages in 
response to PP, PLA, and mPET and between BMI and CCL18 production by macrophages in response 
to PP, PLA, and mPET.  CRP also negatively correlated with IL-1ra production in response to PP, PLA, 
and mPET. CRP or BMI did not correlate with TNFα production (Table 3).  
 
Differences in monocyte subsets between lean and obese patients 
The percentages of classical monocytes (CD14++CD16-), intermediate monocytes 
(CD14++CD16+), or non-classical monocytes (CD14+CD16++) in peripheral blood were not statistically 
significantly different between lean and obese subjects (Table 4). However, the percentages of 
intermediate monocytes correlated positively with IL-6 for PLA and negatively with the CCL18 protein 
production for PET and mPET, and with IL-1ra for mPET. The percentages of non-classical monocytes 
correlated negatively with CCL18 production when macrophages were cultured on mPET. No 
statistically significant correlations were seen between percentages of monocyte subsets and TNFα 
production by the macrophages cultured on any of the biomaterials (Table 5A). For PP and mPET the 
M1/M2 index significantly correlated with the percentage of classical monocytes. Intermediate 
monocytes significantly correlated negative with the M1/M2 index for mPET. Supplementary Figure 1 
shows that the percentages of monocyte subsets are unaffected before and after thawing. 
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Discussion 
The use of biomaterials has become common in regenerative medicine. The reaction of primary 
human macrophages to biomaterials has been shown in vitro to be biomaterial specific, even when 
an inflammatory situation is simulated [18, 19]. However, the person-dependent foreign body 
response has not been taken into account in these models. In the current explorative study, we 
investigated the effect of obesity, a growing problem in the Western world, on the response of 
macrophages to biomaterials and found that on average macrophages from obese patients respond 
more pro-inflammatory to biomaterials as indicated by higher IL-6 and lower CCL18 and IL-1ra 
production than in macrophages from lean persons that were cultured on the same materials. In 
addition, we found that BMI, serum CRP and percentages of monocyte subsets in the peripheral 
blood correlate with the response of the macrophages to the biomaterials in vitro, and that these 
correlations were biomaterial specific. In addition, we showed that macrophages derived from 
monocytes from obese patients still respond pro-inflammatory, even when they are not in an obese 
environment anymore. To our knowledge, this is the first study that investigated the differences in 
macrophage response to biomaterials between lean and obese patients. 
Obese patients included in this trial had no insulin resistance and therefore, according to the 
WHO criteria, no metabolic syndrome[21]. Because of the strict inclusion and exclusion criteria, such 
as no smoking, no implants, and the absence of diabetes mellitus we assume that the different 
responses to the biomaterials between lean and obese patients is the result of obesity only and not 
because of a difference in the presence of diabetes or previous operations in which biomaterials 
were used. However, certain risk factors that are unknown at the moment might have influenced our 
measurements and have resulted in the large variation that is sometimes observed in the cytokine 
measurements. Although these patients do not have a metabolic syndrome, 50% of them had a CRP 
level >10 mg/L, indicating systemic low-grade inflammation. CRP levels in the serum correlated 
positively with IL-6 production by the macrophages on PP and mPET and negatively with CCL18 and 
IL-1ra levels on PP, PLA and mPET in vitro, showing that CRP has a pro-inflammatory effect on 
macrophages. This was supported by an in vitro study, where it was shown that CRP polarizes human 
macrophages to an M1 phenotype[22]. A shift from classic monocytes in the peripheral blood to 
intermediate or non-classic monocytes has been seen before as a result of obesity [11, 23, 24], of 
which the latter two subsets are regarded as the pro-inflammatory subsets with increasing CD16 
positivity[11, 23, 24]. We did not observe a statistically significant shift when comparing the presence 
of these subsets between lean persons and obese patients. This can be due to the fact that the 
inclusion criteria were strict and only obese patients without a metabolic syndrome were included. In 
addition, the numbers of patients from who we were able to obtain a sufficient number of 
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monocytes to perform additional flow cytometric analysis next to culture with biomaterials were low 
and thus resulting in a low power. Interestingly however, when comparing percentages of monocyte 
subsets in the peripheral blood with the cytokine production of monocyte-derived macrophages on 
biomaterials in vitro, CCL18 and IL-1ra production by macrophages on mPET and PET in vitro were 
correlated with the percentages of the different monocyte subsets in the peripheral blood. The 
percentages of classical monocytes correlated positively with CCL18 and IL-1ra levels produced by 
macrophages in culture, the percentages of the more pro-inflammatory intermediate and non-
classical subsets correlated negatively with CCL18 production in culture. CCL18 is a chemokine that is 
predominantly made by anti-inflammatory macrophages [18, 25], indicating that the initial presence 
of classical monocytes is associated with the differentiation towards anti-inflammatory macrophages. 
As could be seen from the individual levels of IL-6, CCL18 and IL-1ra, not all obese patients had 
macrophages producing high levels of IL-6 and low levels of CCL18 or IL-1ra. No corrections for 
baseline production of the cytokines of interest were made however, because in our opinion, this 
best represents the in vivo situation. Even though no corrections were made, differences were still 
seen between the effects of different biomaterials on cells of the same patient. This underlines 
potential patient specific responses even when obesity already changed the metabolic status of the 
patient and these responses can be explained by serum CRP levels and percentages of monocyte 
subsets in the blood. The production of TNFα in our culture system was not influenced by obesity, 
this might be explained by the short time detection range of TNFα[26]. Based on our data, it seems 
that PLA followed by PP and PET, are more preferable for obese patients and that all tested materials 
can be more or less equivalently be used for lean for lean patients, assuming that a pre-dominant 
anti-inflammatory reaction is preferred. Although the choice of material may be better guided by the 
inflammatory reaction at the individual patient level rather than at the comorbidity category such as 
obesity. As shown in previous clinical studies, no enormous undesirable behavior of multifilament 
PET mesh (e.g. Parietex™ Composite mesh) for hernia repair in obese patients has been reported till 
now, therefore the clinical impact might be moderate[27, 28]. Nevertheless the patients outcome 
can always be improved with careful and personalized selection of meshes. 
The polymers used in this study are commonly used for materials for soft tissue repair. The 
host-response to materials is not only material dependent but also the porosity, topography, and 
surface of the material influence the biocompatibility[3, 29-31]. The many different properties of the 
material influence the polarization of the macrophages[3].  In the current study, the materials were 
braided in the same way, but because of different diameters of the individual fibers between the 
materials, the topography was not exactly the same. Therefore the length of the knitted yarn was 
adjusted to the diameter to achieve the best possible comparable material appearance. Interestingly, 
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PET and mPET resulted in different M1/M2 indexes, especially when macrophages of obese patients 
were cultured on the materials. This demonstrates that indeed not only the polymer but also the 
architecture of the material is important for elicited responses. In this study, PP did not elicit an anti-
inflammatory effect based on the cytokines measured. This underlines again that not only the 
polymer itself is important for the reaction the material elicits, but also the architecture of the 
material since in our earlier studies we have used meshes instead of yarns[18, 19]. Braided yarns 
were chosen in the current study to make the macrophage-biomaterial contact more optimal 
necessary for the low numbers of patient cells available for this study. After spiking of IL-6, TNFα, 
CCL18, and IL-1ra in the culture medium, adsorption was seen, and varying between the materials. 
Since PP had the most adsorption of our proteins of interest, the values for PP (and for PLA in the 
case of IL6) are most likely an underestimation. However, most of the associations and comparisons 
are made within a biomaterial and a cytokine, not comparing two different cytokines or materials 
with each other. These comparisons and associations are therefore unaffected in our opinion by the 
adsorption of the protein of interest.  However, the difference in adsorption to each material, and 
especially the high adsorption to PP, might overshadow the differences in reactions elicited by the 
materials. 
After implantation, the biomaterial eventually will be in contact with macrophages, but it will 
also be surrounded by non-adherent macrophages and extracellular matrix. We however specifically 
chose not to included non-adherent macrophages in our experimental set-up. The biomaterials were 
cultured plates made of tissue culture polystyrene (TCPS), also a polymer. By transferring the 
materials with their adherent cells to new wells, the medium contained mainly the cytokines from 
the macrophages adhering to the yarns. TCPS most likely will have a totally different effect than the 
extracellular matrix that normally surrounds an implanted biomaterial. In fact, we have seen that 
collagen indeed exerts different effect on macrophages than polymers [18, 19]. Therefore, we 
believed that including cytokine production from macrophages adhering to the TCPS would make the 
system even more artificial. 
The proteins IL-6, TNFα, CCL18, and IL-1ra were selected as indicators of pro-inflammatory 
and anti-inflammatory responses. We are aware that these cytokines do not represent the full 
spectrum of mediators produced during the foreign body response. However previously, we have 
seen that these mediators are most discriminative between pro-inflammatory and anti-inflammatory 
macrophages[18, 25]. Studies to determine the actual in vivo response to the biomaterial and 
correlating this with the parameters in the peripheral blood are necessary to draw more firm 
conclusions about the predictive value of monocyte subset percentages and serum CRP levels for the 
reaction biomaterials elicit in a certain patient.  
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Conclusion 
Monocyte-derived macrophages of obese patients respond more pro-inflammatory and less anti-
inflammatory to biomaterials than macrophages from lean subjects and this response depends on 
the type of biomaterial. This variation in cytokine production by the macrophages was associated by 
the percentages of monocyte subsets in the peripheral blood, serum CRP levels, or BMI of the 
patient. The  results of this in vitro study offer possibilities and could stimulate future research 
towards personalized medicine, eventually leading to a model that can be used to test biomaterials 
for tissue repair and tissue engineering using patient’s own cells prior to implantation of a 
biomaterial. In addition, our results offer the prospect that monocyte subsets in the blood or serum 
CRP might be measured prior to surgery to predict which biomaterial might be suitable for each 
patient. Studies indeed examining the clinical outcome after implantation of a biomaterial in relation 
to serum CRP, BMI, and monocyte subsets are however needed to confirm this.  
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Figure 1 Experimental flow of our study, including pictures of the yarns and how the yarns were 
placed in the culture wells. CD14 = cluster of differentiation 14, PP = polypropylene, PLA = polylactic 
acid, PET = monofilament polyethylene terephthalate, and mPET = multifilament polyethylene 
terephthalate.  
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Table 1. Patient characteristics lean group vs obese patients. 
 
lean (n=20) obese (n=20) p-value 
BMI (kg/m2) 22.9 ± 2.6 43.8 ± 6.5 <0.001 
gender (male/ female) 2/18 2/18 1.0 
age (years) 41.8 ± 13.1 41.3 ± 13.5 0.916 
use of statins 0/20 2/20 0.154 
  Values are means (SD), p-value was estimated by using independent sample T-test 
 
Table 2. The average production of IL-6, TNFα, CCL18, and IL-1ra corrected for DNA by macrophages 
on the different materials.  
 
  
  cytokine production by macrophages 
(pg protein/ng DNA)   
cytokine material 
lean             
(mean ± SD) 
obese                     
(mean ± SD) p value 
IL-6 PP 116.6 ± 97.2 172.4 ± 114.1 0.106 
 
PLA 109.2 ± 67.1 157.4 ± 146.8 0.247 
 
PET 102.0 ± 73.9 144.0 ± 58.4 0.022 
 
mPET 39.2 ± 23.9 68.7 ± 64.0 0.140 
TNFα PP 7.9 ± 8.3 5.9 ± 4.9 0.300 
 PLA 5.0 ± 4.4 3.3 ± 3.1 0.119 
 PET 3.6 ± 3.8 3.3 ± 1.5 0.417 
 mPET 1.0 ± 0.9 0.7 ± 0.5 0.421 
CCL18 PP 0.8 ± 0.7 0.2  ± 0.3 < 0.001 
 PLA 1.4 ± 0.9 0.4 ± 0.4 0.002 
 PET 1.6 ± 1.3 0.5 ± 0.6 0.002 
 mPET 0.7 ± 0.6 0.3 ± 0.3 0.007 
IL-1ra PP 49.4 ± 52.2 24.4 ± 16.8 0.128 
 PLA 34.6 ± 28.5 15.5 ± 9.0 0.026 
 PET 32.3 ± 22.6  20.2 ± 13.6 0.071 
 mPET 18.0 ± 18.4 10.0 ± 12.3 0.057 
Bold values denote statistical significance 
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Figure 2: Measurements of IL-6 (A), TNF (B), CCL18 (C), and IL-1ra (D) in the culture medium with 
and without the incubation of the biomaterials and with and without spiking of the protein of 
interest. White bar indicates measurements in medium with or without incubation of the materials. 
Black bars indicate measurements in medium alone or after incubation with the material in the 
presence of the spiked proteins. Bars represent n= 6 + sd for every bar.  
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Figure 3 Cytokine production corrected for DNA compared per material, in lean subjects or in obese 
subjects. Number of patients per cytokine and per material are indicated in the bars or just above the 
error bar. 
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Figure 4: M1/M2 index between materials. Bars represent the mean, error bars the SD, p-values 
indicate significant differences. A base 2-log scale is used for the Y-axis. PP = polypropylene, PLA = 
polylactic acid, PET = monofilament polyethylene terephthalate, and mPET = multifilament 
polyethylene terephthalate. The number of patients included per material, per group are indicated in 
the bars. 
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Table 3 Correlations between CRP concentration in peripheral blood, BMI of all subjects, and 
cytokine production by the macrophages.  
  
CRP BMI 
 
material r p- value r p-value 
CRP - - - 0.64 < 0.001 
IL-6 PP 0.37 0.046 0.27 0.111 
 
PLA 0.20 0.310 0.22 0.198 
 
PET 0.40 0.035 0.27 0.146 
 
mPET 0.53 0.003 0.22 0.186 
CCL18 PP -0.45 0.012 -0.44 0.006 
 
PLA -0.56 0.002 -0.37 0.028 
 
PET -0.36 0.063 -0.39 0.017 
 
mPET -0.54 0.002 -0.30 0.068 
IL-1ra PP -0.36 0.05 -0.15 0.391 
 
PLA -0.45 0.015 -0.20 0.245 
 
PET -0.35 0.075 -0.22 0.211 
 
mPET -0.54 0.013 -0.22 0.267 
TNFα PP -0.17 0.382 -0.18 0.295 
 
PLA -0.15 0.438 -0.24 0.16 
 
PET 0.14 0.492  0.02 0.903 
 
mPET -0.17 0.476 -0.30 0.143 
Bold values denote statistically significant p-values 
 
 
Table 4 Percentages of peripheral blood monocytes subsets in lean (n = 9) and obese (n = 8) subjects. 
Values are mean +/- sd.   
% of monocyte lean obese p-value 
classical (CD14++CD16-) 90.9 ± 5.3 77.4 ± 22.0 0.290 
intermediate (CD14++CD16+) 2.2 ± 3.4 7.9 ± 13.4 0.336 
non-classical (CD14+CD16++) 4.0 ± 3.8 12.9 ± 13.7 0.211 
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Table 5A Spearman correlation between percentages of CD14++CD16- (classical), CD14++CD16+ 
(intermediate), or CD14+CD16++ (non-classical) monocyte subsets and production of cytokines by 
cultured macrophages on the four different materials. The Spearman correlation coefficients (r) 
define the relationship between monocyte subsets from peripheral blood and the production of IL-6, 
CCL18, IL-1ra, and TNFα) by macrophages cultured on PP, PLA, PET, and mPET. Table 5B shows the 
correlation between the percentages of monocyte subsets with the M1/M2 index for the four 
different materials. PP = polypropylene, PLA = polylactic acid, PET = monofilament polyethylene 
terephthalate, and mPET = multifilament polyethylene terephthalate. 
A 
 
CD14++CD16- CD14++CD16+ CD14+CD16++ 
 
material r p- value r p-value r p-value 
CRP - -0.42 0.120 0.35 0.198 0.35 0.203 
BMI   -0.16 0.535 0.12 0.636 0.31 0.231 
IL-6 PP -0.17 0.541 0.27 0.334 0.26 0.355 
 PLA -0.43 0.086 0.53 0.028 0.41 0.103 
 PET -0.54 0.038 0.51 0.052 0.47 0.079 
  mPET -0.36 0.158 0.38 0.133 0.26 0.323 
CCL18 PP 0.28 0.321 -0.13 0.639 -0.23 0.405 
 PLA 0.16 0.549 -0.32 0.107 -0.18 0.370 
 PET 0.21 0.451 -0.40 0.045 -0.36 0.073 
  mPET 0.24 0.353 -0.50 0.007 -0.39 0.039 
IL-1ra PP 0.12 0.676 -0.43 0.108 0.18 0.516 
 
PLA 0.16 0.529 -0.29 0.252 0.04 0.889 
 
PET 0.28 0.334 -0.65 0.011 -0.03 0.911 
 
mPET 0.13 0.658 -0.53 0.052 0.16 0.594 
TNFα PP -0.37 0.173 0.17 0.550 0.42 0.121 
 
PLA -0.35 0.171 0.37 0.141 0.21 0.428 
 
PET -0.46 0.084 0.30 0.283 0.30 0.296 
 
mPET -0.41 0.167 0.01 0.986 0.42 0.152 
  
B Spearman correlation between percentages of monocyte subsets and M1/M2 index 
  
CD14++CD16- CD14++CD16+ CD14+CD16++ 
 
material r p-value R p-value r p-value 
M1/M2 PP -0.59 0.020 0.36 0.182 0.48 0.069 
 PLA -0.40 0.112 0.37 0.144 0.35 0.174 
 PET -0.45 0.092 0.26 0.341 0.27 0.328 
  mPET -0.51 0.038 0.58 0.016 0.41 0.098 
Bold values denote statistically significant p-values   
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Supplementary data 
Supplementary figure 1; flow cytometric analysis of fresh (A, B), and frozen monocytes (C, D). 
Forward scatter (FSC) and sideward scatter (SSC) show size and granularity of the cells (A, C) and 
monocyte subsets were determined based on the presence of cluster of differentiation 14 (CD14) 
and CD16 (B, D).  
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Supplementary Figure 2A: IL-6, B: TNFα, C CCL18, D IL-1ra production by macrophages seeded on 
different materials corrected for DNA, lean vs. obese groups shown per material. Every dot 
represents a single donor. The line indicates the mean, p-values indicate a statistically significant 
difference. Bars represent the mean, whiskers the SD. Ratios underneath the graphs indicate the 
male/female ratio per measurement and per material. PP = polypropylene, PLA = polylactic acid, PET 
= monofilament polyethylene terephthalate, and mPET = multifilament polyethylene terephthalate. 
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Supplementary Figure 3A. The amount of DNA as indication of the number of attached macrophages 
to the biomaterials. DNA is shown as ng/mL for polypropylene (PP), polylactic acid (PLA), 
monofilament polyethylene terephthalate (PET), and multifilament polyethylene terephthalate 
(mPET) for the lean (open bars) and obese (dotted bars) donors. Bars represent mean ± S.E.M. n = 20 
donors/ group, three samples/ per material/ per donor, p-value indicates a significant difference. 
Figure 3B, C, D, E Comparing macrophages from lean and obese donors cultured on different 
materials regarding B) IL-6 production and C) TNFα production and D) CCL18 production and E) IL-1ra 
production in ng/ml after 3 days of culture. Every dot represents a single donor. Line and whiskers 
indicate mean ± S.E.M., p-values indicate a statistically significant difference. PP = polypropylene, PLA 
= polylactic acid, PET = monofilament polyethylene terephthalate, and mPET = multifilament 
polyethylene terephthalate. 
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Figure 4 C-reactive protein (CRP) levels in mg/L in plasma of lean subjects vs. obese patients. 
The middle line in box represent the median and whiskers the minimum and 
maximum; lean (0-7 mg/L) and  obese (0-75 mg/L).  
le
an
ob
es
e
0
10
20
30
40
50
60
70
80
C
R
P
 m
g
/L
 
 
 
 
 
  
manuscript with remarks (changes)
Click here to download Supplementary Files: Biomaterials Manuscript Informed trial 27062016 remarks.docx
point-by-point response
Click here to download Supplementary Files: Reply to reviewers inFORMED.docx
